Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation

被引:14
|
作者
Grat, Karolina [1 ]
Pacho, Ryszard [1 ]
Grat, Michal [2 ]
Krawczyk, Marek [2 ]
Zieniewicz, Krzysztof [2 ]
Rowinski, Olgierd [1 ]
机构
[1] Med Univ Warsaw, Dept Clin Radiol 2, PL-02097 Warsaw, Poland
[2] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, PL-02097 Warsaw, Poland
关键词
obesity; hepatocellular carcinoma; liver transplantation; subcutaneous fat; visceral fat; computed tomography; adipose tissue; sarcopenia; VISCERAL ADIPOSITY; GASTRIC-CANCER; SARCOPENIA; OBESITY; RESECTION; OUTCOMES; HEPATECTOMY; PROGNOSIS; SURVIVAL; LEPTIN;
D O I
10.3390/jcm8101672
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Body composition parameters are reported to influence the risk of hepatocellular carcinoma (HCC) recurrence after liver resection, yet data on patients undergoing liver transplantation are scarce. The aim of this study was to evaluate the impact of the amount of abdominal adipose tissue and skeletal muscles on the risk of HCC recurrence after liver transplantation. Methods: This was a retrospective observational study performed on 77 HCC patients after liver transplantation. Subcutaneous fat area (SFA), visceral fat area, psoas muscle area and total skeletal muscle area were assessed on computed tomography on the level of L3 vertebra and divided by square meters of patient height. The primary outcome measure was five-year recurrence-free survival. Results: Recurrence-free survival in the entire cohort was 95.7%, 90.8%, and 86.5% after one, three, and five years post-transplantation, respectively. SFA was significantly associated with the risk of HCC recurrence (p = 0.013), whereas no significant effects were found for visceral fat and skeletal muscle indices. The optimal cut-off for SFA for prediction of recurrence was 71.5 cm(2)/m(2). Patients with SFA < 71.5 cm(2)/m(2) and >= 71.5 cm(2)/m(2) exhibited five-year recurrence-free survival of 96.0% and 55.4%, respectively (p = 0.001). Conclusions: Excessive amount of subcutaneous adipose tissue is a risk factor for HCC recurrence after liver transplantation and may be considered in patient selection process.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Impact of Sirolimus on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
    Chinnakotla, Srinath
    Davis, Gary L.
    Vasani, Sugam
    Kim, Peter
    Tomiyama, Koji
    Sanchez, Edmund
    Onaca, Nicholas
    Goldstein, Robert
    Levy, Marlon
    Klintmalm, Goeran B.
    LIVER TRANSPLANTATION, 2009, 15 (12) : 1834 - 1842
  • [2] Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Recurrence Characteristics and Risk Factors
    Li, Chuan
    Wen, Tian-Fu
    Liao, Zhi-Xue
    Yan, Lv-Nan
    Li, Bo
    Zeng, Yong
    Wang, Wen-Tiao
    Xu, Ming-Qing
    Yang, Jia-Ying
    Wei, Yong-Gang
    HEPATO-GASTROENTEROLOGY, 2010, 57 (99-100) : 567 - 570
  • [3] Hepatocellular Carcinoma Recurrence After Liver Transplantation
    Gabutti, Alejandro
    Bhoori, Sherrie
    Cascella, Tommaso
    Bongini, Marco
    ONCOLOGY-NEW YORK, 2020, 34 (03): : 91 - 94
  • [4] No impact of donor sex on the recurrence of hepatocellular carcinoma after liver transplantation
    Taura, Kojiro
    Shimamura, Tsuyoshi
    Akamatsu, Nobuhisa
    Umeshita, Koji
    Fujiyoshi, Masato
    Abe, Hiroyasu
    Morita, Satoshi
    Uemoto, Shinji
    Eguchi, Susumu
    Furukawa, Hiroyuki
    Takada, Yasutsugu
    Egawa, Hiroto
    Ohdan, Hideki
    Hatano, Etsuro
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2022, 29 (05) : 570 - 584
  • [5] Recurrence of hepatocellular carcinoma after liver transplantation
    Escartin, A.
    Sapisochin, G.
    Bilbao, I.
    Vilallonga, R.
    Bueno, J.
    Castells, L.
    Dopazo, C.
    Castro, E.
    Caralt, M.
    Balsells, J.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (07) : 2308 - 2310
  • [6] Impact of donor characteristics on hepatocellular carcinoma recurrence after liver transplantation
    Akabane, Miho
    Bekki, Yuki
    Imaoka, Yuki
    Inaba, Yosuke
    Esquivel, Carlos O.
    Melcher, Marc L.
    Kwong, Allison
    Sasaki, Kazunari
    BRITISH JOURNAL OF SURGERY, 2024, 111 (04)
  • [7] Early Reoperation and Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation
    Elsabbagh, Ahmed
    Girlanda, Raffaele
    Mckesey, Jacqueline
    Kroemer, Alexander
    Hawksworth, Jason
    Matsumoto, Cal
    Fishbein, Thomas
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 76 - 76
  • [8] Everolimus mitigates the risk of hepatocellular carcinoma recurrence after liver transplantation
    De Simone, Paolo
    Precisi, Arianna
    Lai, Quirino
    Ducci, Juri
    Campani, Daniela
    Marchetti, Piero
    Gitto, Stefano
    JOURNAL OF HEPATOLOGY, 2024, 80 : S456 - S456
  • [9] Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation
    Zhang, Xu
    Chen, Chi
    Wang, Yan
    Xu, Jun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (11) : 2272 - 2280
  • [10] Donor Quality and the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation
    Orci, Lorenzo A.
    Majno, Pietro E.
    Lacotte, Stephanie
    Mentha, Gilles
    Toso, Christian
    LIVER TRANSPLANTATION, 2014, 20 : S148 - S149